Lv4
450 积分 2024-05-11 加入
Aspartate aminotransferase and mortality in patients with ischemic heart disease
22天前
已关闭
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
25天前
已完结
FIB-4 Predicts MACE and Cardiovascular Mortality in Patients With Nonalcoholic Fatty Liver Disease
30天前
已完结
Liver fibrosis scores and prognosis in patients with cardiovascular diseases: A systematic review and meta-analysis
30天前
已完结
Diagnosis and Management of Prediabetes
1个月前
已完结
Fluorofenidone protects against acute liver failure in mice by regulating MKK4/JNK pathway
1个月前
已完结
Isthmin-1 alleviates cardiac ischaemia/reperfusion injury through cGMP-PKG signalling pathway
1个月前
已完结
[Advances in research on ferroptosis and pancreatic islet beta-cell function]
2个月前
已完结
SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease
3个月前
已关闭
SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis
3个月前
已完结
皖公网安备34019202002308
